Codiak BioSciences gets grant for extracellular vesicles for disease treatment and prevention

Discover Codiak BioSciences’ groundbreaking patent on engineered extracellular vesicles (EVs) for targeted disease treatment, including cancer and infections.

Meet this year’s Endpoints 11; J&J winds down cardiovascular and metabolic unit; BMS wins schizophrenia approval; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 29, 2024

Evolving brain sizes from 1930 to 1970 could signal decreased dementia risk, researchers say

Changes in skull and brain size, as well as the thickness of the cortex, across individuals born between the years 1930 and 1970.

March 27, 2024

Putting Together the Puzzle Pieces of Self-Compassion

Listen and subscribe/follow on Apple and Spotify so you don’t miss the next episode. And if you like what you hear, a five-star rating goes

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.